Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I believe testing was actually conducted by Dr Gene Olinger who now runs the level 4 lab at NIH. Search the internet for Olinger's papers and presentations. He has a history with NanoViricides. Perhaps he'll have a future as well?
You're on a comedic roll. Enjoying every post.
Search for Ebola, Olinger and Scully and in no time you'll find papers supporting the JPEG BK posted. You might also look into current activities of Olinger. Doing contracted work for NIH. NIH, where there exists a containment lab ideal for live animal Ebola testing.
Terrific activity today. Investors appear to approve of the formalization of organizational structure and Management selected for the Oil sector. Of course it is also possible that contracts are being signed and product is reaching the field. Business growth will not go unnoticed by those hoping to ride IET's coat tails.
Hiring Bradley W. Rockman to oversee its oil and gas operations is a tremendously positive step for IET. I believe it signals a transition to revenue generation.
Obviously? Based on what might I ask? Your DD generally digs no deeper then this board. Is this another parrot opinion on your part?
Please enlighten the board. Provide the documented source or sources that led you to your conclusion.
There is room for interpretation. I don't agree with your interpretation. I would interpret the statement to mean that future activities requiring large quantities of viricides will be easily managed in the new facility.
Thank you for this post.
Glad to be wrong. It indicates that investors, insiders as well as retail, are anticipating revenue before the end on the year.
I think there is potential. I am holding. I anticipate a sell off. I hope SP will recover close to .065 leading up to Q3 report. If so and with some positive PR I think there will be money to make in Q4.
The 10Q was a pig. (Like all previous.). There has been a SP run up, I think, in anticipation of revenues reported. I for one did not expect revenue. If IEVM is going to survive, perhaps even thrive, the evidence will come in Q3 and Q4 reports.
I expect a sell off Monday. Baring a PR. I anticipate recent investors to react very negatively to the Q2 10Q. I may regret it but I'm holding on for Q3.
One investors perspective. Here's another.
Amassed a position over 6 years, averaging down along the way until I achieved my target position at .67/share pre split. Well into the green.
I believe NanoViricides is progressing toward success.
Others who bought high and sold low believe they were fleeced.
Do you think the trade balance may introduce a bias? Of course. Keep that in mind when considering my positive posts regarding NNVC, apply equal amounts of salt when considering the condemnations of others.
And most of all beware of those who claim to post for altruistic purposes.
Do your own DD.
Thank you, and others, for providing third party validations of NanoViricides' accomplishments. I am limited to one post per day and therefore could not reply to the request.
Gravity? It's so much easier to hold the price down then it is to get it off the ground. MM are in the business of stabilizing markets and reducing wild SP volatility. They are earning their money with IEVM. The SP won't move significantly on speculation. Published results will be required if there is to be a breakout.
No tie! Sell, sell, sell!
I won't venture a dollar value guess, but I'd hope to see modest revenue reported in Q3 and 3x to 4x revenue growth in Q4.
Today's PR was bold. It was encouraging that IEVM was willing to entertain potential short term growth openly and precisely. I stick to my projection, the next two quarterly statements will be telling.
I think retirement is still a ways off but SP should enjoy a health increase.
Revenue in the next two quarters will signal a validation of IEVM's technology and their business plan. The market will reward investors.
True, also recognize the desire to optimize FluCide and the requirement to perform Toxicity tests on that optimized, IND Candidate, version of FluCide.
It took time to arrive at a formulation that all believed was ideal for a run at FDA and EMA approval.
Measure twice, cut once.
The next two quarterly reports will tell all. If they've converted Utah POC into a Utah contract the dollars will show. Let's hope they closed a deal.
Ironic. Mom always said I bugged her.
Good to have your periodic posts. You bring strong insights to the board.
Happy 4th.
Fascinating post. Thank you for regularly posting educational and/or thought provoking breakthroughs.
Thank you for your analysis. Your insight is very helpful.
Look at the one day chart. Multiple buyers purchased almost a millions shares after the close. Looks like good news may be coming.
Today's PR signals the opening of a second line of revenue generation.
Revenue line 1- the fracking fields
Revenue line 2- the medical field
Terrific news. Rarely does a post to this board bring such wonderful news with true importance. I am happy for you, your family and of course your father.
Vaccinations are one of the most controversial issues....
Until you take a moment to review and rely on the overwhelming majority of Immunologists and experts in the science of infectious disease. If you traffic in disproved, flawed, biased and discredited studies and the ranting of celebrity spokes-idiots it may be controversial.
CDC or Jenny McCarthy, Wakefield, Father and Son faux-science?
Really?
Controversial?
Perhaps to Oprah's viewers.
And Soylent Green is people!
Intercept received mention in a NYTimes article this morning.
http://well.blogs.nytimes.com/2014/06/13/threat-grows-from-liver-illness-tied-to-obesity/?emc=edit_th_20140614&nl=todaysheadlines&nlid=49427619
Galectin received mention in a NYTimes article this morning.
http://well.blogs.nytimes.com/2014/06/13/threat-grows-from-liver-illness-tied-to-obesity/?emc=edit_th_20140614&nl=todaysheadlines&nlid=49427619
When (if), the sale is reported we'll look forward to your documented confirmation. Until then your speculation will have to be considered a HO. Please be sure to communicate the facts when you get some. Thanks.
NNVC has invested time and money. Shareholders have bought the risk. It is my preference as a long that NNVC run solo as long as possible assume the risk and reap the rewards of a deal made from a position of strength.
2 steps forward 1 step back. Predicting delays is no trick, this is pioneering science delays are par for the course. Progress is being made. If you have a spy then you know the lab will open, Tox will start, MERSCide, FluCide, DengueCide....will be tested. Nothing said on this board will impact the results on those tests. The lunch menu will not contribute to the results.
Like fans watching a ballgame. Pick your team and root, root, root for a victory. Sportsmanship dictates respect for the opponent. That seems to have gone out of fashion. Common courtesy dictates respect for the opposition's fans. Lately home fans have resorted to beating opposing supporters up in the parking lot. No class.
Hoping for a strong week and, overall, a strong June. GLTA
Institutional investing accelerating.
Share liquidity resulting.
Share price rising.
PRs coming.
Split.
2014,2015...boom!
Recent weeks have been pleasant. Much preferred to a stick in the eye. But, I will feel more comfortable when the rise in share price is accompanied by or initiated by one or more key milestones. There are a number of activities; Shelton Go Live, PHE results, MERS news, additional Dengue validation, BASi Tox progress...that could trigger a strong run up. For those who have offered a wager I'll take NNVC in the winner's circle. I am confident that multiple key milestones will be met before the end of the year. For those of us measuring progress on a scale of years I am confident 2014 will be very profitable.
9/17/13. no news, no discernible cause, no fun
???? No. No, desperation, I'm up.
I don't think Tox has begun. I don't think Tox start will be announced, or maybe better said, I don't think Tox start SHOULD be announced.
PR results not promise.
Happy holiday weekend to all.
I agree. Revenue announcements in the next Q must show growth and potential. A business opportunity was spelled out in the conference call. It remains to be seen if Well operators recognize Operational advantages and cost reduction.